PubMed:1820202 / 129-398 JSONTXT

{"project":"LitCoin-PubTator-for-Tuning","denotations":[{"id":"20","span":{"begin":0,"end":36},"obj":"ChemicalEntity"},{"id":"21","span":{"begin":38,"end":49},"obj":"ChemicalEntity"},{"id":"22","span":{"begin":79,"end":86},"obj":"ChemicalEntity"},{"id":"23","span":{"begin":87,"end":99},"obj":"ChemicalEntity"},{"id":"24","span":{"begin":109,"end":130},"obj":"DiseaseOrPhenotypicFeature"},{"id":"25","span":{"begin":145,"end":156},"obj":"ChemicalEntity"},{"id":"26","span":{"begin":184,"end":208},"obj":"ChemicalEntity"}],"attributes":[{"id":"A22","pred":"tao:has_database_id","subj":"22","obj":"MESH:D014531"},{"id":"A24","pred":"tao:has_database_id","subj":"24","obj":"MESH:C562719"}],"text":"Aryl-N-acetyl-alpha-galactosaminides (aryl-GalNAc) are acceptor substrates for UDP-Gal:alpha-GalNAc beta 1-3 galactosyltransferase and, in vivo, aryl-GalNAc have been shown to inhibit O-linked oligosaccharide biosynthesis (Kuan et al., J. Biol. Chem. 264, 19271, 1989)."}

{"project":"sentences","denotations":[{"id":"TextSentencer_T2","span":{"begin":0,"end":238},"obj":"Sentence"},{"id":"TextSentencer_T3","span":{"begin":239,"end":244},"obj":"Sentence"},{"id":"TextSentencer_T4","span":{"begin":245,"end":250},"obj":"Sentence"},{"id":"TextSentencer_T5","span":{"begin":251,"end":269},"obj":"Sentence"},{"id":"T2","span":{"begin":0,"end":269},"obj":"Sentence"},{"id":"T2","span":{"begin":0,"end":238},"obj":"Sentence"},{"id":"T3","span":{"begin":239,"end":244},"obj":"Sentence"},{"id":"T4","span":{"begin":245,"end":250},"obj":"Sentence"},{"id":"T5","span":{"begin":251,"end":269},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Aryl-N-acetyl-alpha-galactosaminides (aryl-GalNAc) are acceptor substrates for UDP-Gal:alpha-GalNAc beta 1-3 galactosyltransferase and, in vivo, aryl-GalNAc have been shown to inhibit O-linked oligosaccharide biosynthesis (Kuan et al., J. Biol. Chem. 264, 19271, 1989)."}

{"project":"GlycoBiology-FMA","denotations":[{"id":"_T5","span":{"begin":20,"end":36},"obj":"FMAID:82792"},{"id":"_T6","span":{"begin":20,"end":36},"obj":"FMAID:196787"},{"id":"_T7","span":{"begin":193,"end":208},"obj":"FMAID:196731"},{"id":"_T8","span":{"begin":193,"end":208},"obj":"FMAID:82742"}],"namespaces":[{"prefix":"FMAID","uri":"http://purl.org/sig/ont/fma/fma"}],"text":"Aryl-N-acetyl-alpha-galactosaminides (aryl-GalNAc) are acceptor substrates for UDP-Gal:alpha-GalNAc beta 1-3 galactosyltransferase and, in vivo, aryl-GalNAc have been shown to inhibit O-linked oligosaccharide biosynthesis (Kuan et al., J. Biol. Chem. 264, 19271, 1989)."}

{"project":"uniprot-human","denotations":[{"id":"T1","span":{"begin":100,"end":106},"obj":"http://www.uniprot.org/uniprot/Q92988"}],"text":"Aryl-N-acetyl-alpha-galactosaminides (aryl-GalNAc) are acceptor substrates for UDP-Gal:alpha-GalNAc beta 1-3 galactosyltransferase and, in vivo, aryl-GalNAc have been shown to inhibit O-linked oligosaccharide biosynthesis (Kuan et al., J. Biol. Chem. 264, 19271, 1989)."}

{"project":"uniprot-mouse","denotations":[{"id":"T1","span":{"begin":109,"end":130},"obj":"http://www.uniprot.org/uniprot/P23336"}],"text":"Aryl-N-acetyl-alpha-galactosaminides (aryl-GalNAc) are acceptor substrates for UDP-Gal:alpha-GalNAc beta 1-3 galactosyltransferase and, in vivo, aryl-GalNAc have been shown to inhibit O-linked oligosaccharide biosynthesis (Kuan et al., J. Biol. Chem. 264, 19271, 1989)."}

{"project":"GlycoBiology-NCBITAXON","denotations":[{"id":"T2","span":{"begin":100,"end":104},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/158455"},{"id":"T3","span":{"begin":100,"end":104},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/3554"}],"text":"Aryl-N-acetyl-alpha-galactosaminides (aryl-GalNAc) are acceptor substrates for UDP-Gal:alpha-GalNAc beta 1-3 galactosyltransferase and, in vivo, aryl-GalNAc have been shown to inhibit O-linked oligosaccharide biosynthesis (Kuan et al., J. Biol. Chem. 264, 19271, 1989)."}

{"project":"GO-BP","denotations":[{"id":"T2","span":{"begin":193,"end":221},"obj":"http://purl.obolibrary.org/obo/GO_0009312"},{"id":"T4","span":{"begin":209,"end":221},"obj":"http://purl.obolibrary.org/obo/GO_0009058"},{"id":"T5","span":{"begin":228,"end":230},"obj":"http://purl.obolibrary.org/obo/GO_0004306"}],"text":"Aryl-N-acetyl-alpha-galactosaminides (aryl-GalNAc) are acceptor substrates for UDP-Gal:alpha-GalNAc beta 1-3 galactosyltransferase and, in vivo, aryl-GalNAc have been shown to inhibit O-linked oligosaccharide biosynthesis (Kuan et al., J. Biol. Chem. 264, 19271, 1989)."}

{"project":"GlyTouCan-IUPAC","denotations":[{"id":"GlycanIUPAC_T2","span":{"begin":43,"end":49},"obj":"\"http://rdf.glycoinfo.org/glycan/G23425WZ\""},{"id":"GlycanIUPAC_T3","span":{"begin":93,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G23425WZ\""},{"id":"GlycanIUPAC_T4","span":{"begin":150,"end":156},"obj":"\"http://rdf.glycoinfo.org/glycan/G23425WZ\""},{"id":"GlycanIUPAC_T11","span":{"begin":43,"end":49},"obj":"\"http://rdf.glycoinfo.org/glycan/G02874VH\""},{"id":"GlycanIUPAC_T12","span":{"begin":93,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G02874VH\""},{"id":"GlycanIUPAC_T13","span":{"begin":150,"end":156},"obj":"\"http://rdf.glycoinfo.org/glycan/G02874VH\""},{"id":"GlycanIUPAC_T20","span":{"begin":43,"end":49},"obj":"\"http://rdf.glycoinfo.org/glycan/G99699DW\""},{"id":"GlycanIUPAC_T21","span":{"begin":93,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G99699DW\""},{"id":"GlycanIUPAC_T22","span":{"begin":150,"end":156},"obj":"\"http://rdf.glycoinfo.org/glycan/G99699DW\""},{"id":"GlycanIUPAC_T29","span":{"begin":43,"end":49},"obj":"\"http://rdf.glycoinfo.org/glycan/G22074RM\""},{"id":"GlycanIUPAC_T30","span":{"begin":93,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G22074RM\""},{"id":"GlycanIUPAC_T31","span":{"begin":150,"end":156},"obj":"\"http://rdf.glycoinfo.org/glycan/G22074RM\""},{"id":"GlycanIUPAC_T38","span":{"begin":43,"end":49},"obj":"\"http://rdf.glycoinfo.org/glycan/G48535VZ\""},{"id":"GlycanIUPAC_T39","span":{"begin":93,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G48535VZ\""},{"id":"GlycanIUPAC_T40","span":{"begin":150,"end":156},"obj":"\"http://rdf.glycoinfo.org/glycan/G48535VZ\""},{"id":"GlycanIUPAC_T47","span":{"begin":43,"end":49},"obj":"\"http://rdf.glycoinfo.org/glycan/G39738WL\""},{"id":"GlycanIUPAC_T48","span":{"begin":93,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G39738WL\""},{"id":"GlycanIUPAC_T49","span":{"begin":150,"end":156},"obj":"\"http://rdf.glycoinfo.org/glycan/G39738WL\""},{"id":"GlycanIUPAC_T56","span":{"begin":43,"end":49},"obj":"\"http://rdf.glycoinfo.org/glycan/G42313WU\""},{"id":"GlycanIUPAC_T57","span":{"begin":93,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G42313WU\""},{"id":"GlycanIUPAC_T58","span":{"begin":150,"end":156},"obj":"\"http://rdf.glycoinfo.org/glycan/G42313WU\""},{"id":"GlycanIUPAC_T65","span":{"begin":43,"end":49},"obj":"\"http://rdf.glycoinfo.org/glycan/G00393CK\""},{"id":"GlycanIUPAC_T66","span":{"begin":93,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G00393CK\""},{"id":"GlycanIUPAC_T67","span":{"begin":150,"end":156},"obj":"\"http://rdf.glycoinfo.org/glycan/G00393CK\""},{"id":"GlycanIUPAC_T74","span":{"begin":43,"end":49},"obj":"\"http://rdf.glycoinfo.org/glycan/G42649EX\""},{"id":"GlycanIUPAC_T75","span":{"begin":93,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G42649EX\""},{"id":"GlycanIUPAC_T76","span":{"begin":150,"end":156},"obj":"\"http://rdf.glycoinfo.org/glycan/G42649EX\""},{"id":"GlycanIUPAC_T83","span":{"begin":43,"end":49},"obj":"\"http://rdf.glycoinfo.org/glycan/G46880SB\""},{"id":"GlycanIUPAC_T84","span":{"begin":93,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G46880SB\""},{"id":"GlycanIUPAC_T85","span":{"begin":150,"end":156},"obj":"\"http://rdf.glycoinfo.org/glycan/G46880SB\""},{"id":"GlycanIUPAC_T92","span":{"begin":43,"end":49},"obj":"\"http://rdf.glycoinfo.org/glycan/G75599IR\""},{"id":"GlycanIUPAC_T93","span":{"begin":93,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G75599IR\""},{"id":"GlycanIUPAC_T94","span":{"begin":150,"end":156},"obj":"\"http://rdf.glycoinfo.org/glycan/G75599IR\""},{"id":"GlycanIUPAC_T101","span":{"begin":43,"end":49},"obj":"\"http://rdf.glycoinfo.org/glycan/G58985MU\""},{"id":"GlycanIUPAC_T102","span":{"begin":93,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G58985MU\""},{"id":"GlycanIUPAC_T103","span":{"begin":150,"end":156},"obj":"\"http://rdf.glycoinfo.org/glycan/G58985MU\""},{"id":"GlycanIUPAC_T110","span":{"begin":43,"end":49},"obj":"\"http://rdf.glycoinfo.org/glycan/G92517PO\""},{"id":"GlycanIUPAC_T111","span":{"begin":93,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G92517PO\""},{"id":"GlycanIUPAC_T112","span":{"begin":150,"end":156},"obj":"\"http://rdf.glycoinfo.org/glycan/G92517PO\""},{"id":"GlycanIUPAC_T119","span":{"begin":43,"end":49},"obj":"\"http://rdf.glycoinfo.org/glycan/G88512YL\""},{"id":"GlycanIUPAC_T120","span":{"begin":93,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G88512YL\""},{"id":"GlycanIUPAC_T121","span":{"begin":150,"end":156},"obj":"\"http://rdf.glycoinfo.org/glycan/G88512YL\""},{"id":"GlycanIUPAC_T128","span":{"begin":43,"end":49},"obj":"\"http://rdf.glycoinfo.org/glycan/G41473NX\""},{"id":"GlycanIUPAC_T129","span":{"begin":93,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G41473NX\""},{"id":"GlycanIUPAC_T130","span":{"begin":150,"end":156},"obj":"\"http://rdf.glycoinfo.org/glycan/G41473NX\""},{"id":"GlycanIUPAC_T137","span":{"begin":43,"end":49},"obj":"\"http://rdf.glycoinfo.org/glycan/G71089RB\""},{"id":"GlycanIUPAC_T138","span":{"begin":93,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G71089RB\""},{"id":"GlycanIUPAC_T139","span":{"begin":150,"end":156},"obj":"\"http://rdf.glycoinfo.org/glycan/G71089RB\""},{"id":"GlycanIUPAC_T146","span":{"begin":43,"end":49},"obj":"\"http://rdf.glycoinfo.org/glycan/G73485GZ\""},{"id":"GlycanIUPAC_T147","span":{"begin":93,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G73485GZ\""},{"id":"GlycanIUPAC_T148","span":{"begin":150,"end":156},"obj":"\"http://rdf.glycoinfo.org/glycan/G73485GZ\""},{"id":"GlycanIUPAC_T155","span":{"begin":43,"end":49},"obj":"\"http://rdf.glycoinfo.org/glycan/G61406KC\""},{"id":"GlycanIUPAC_T156","span":{"begin":93,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G61406KC\""},{"id":"GlycanIUPAC_T157","span":{"begin":150,"end":156},"obj":"\"http://rdf.glycoinfo.org/glycan/G61406KC\""},{"id":"GlycanIUPAC_T164","span":{"begin":43,"end":49},"obj":"\"http://rdf.glycoinfo.org/glycan/G34412GZ\""},{"id":"GlycanIUPAC_T165","span":{"begin":93,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G34412GZ\""},{"id":"GlycanIUPAC_T166","span":{"begin":150,"end":156},"obj":"\"http://rdf.glycoinfo.org/glycan/G34412GZ\""},{"id":"GlycanIUPAC_T173","span":{"begin":43,"end":49},"obj":"\"http://rdf.glycoinfo.org/glycan/G67209FP\""},{"id":"GlycanIUPAC_T174","span":{"begin":93,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G67209FP\""},{"id":"GlycanIUPAC_T175","span":{"begin":150,"end":156},"obj":"\"http://rdf.glycoinfo.org/glycan/G67209FP\""},{"id":"GlycanIUPAC_T182","span":{"begin":43,"end":49},"obj":"\"http://rdf.glycoinfo.org/glycan/G61442IL\""},{"id":"GlycanIUPAC_T183","span":{"begin":93,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G61442IL\""},{"id":"GlycanIUPAC_T184","span":{"begin":150,"end":156},"obj":"\"http://rdf.glycoinfo.org/glycan/G61442IL\""},{"id":"GlycanIUPAC_T191","span":{"begin":43,"end":49},"obj":"\"http://rdf.glycoinfo.org/glycan/G93729MV\""},{"id":"GlycanIUPAC_T192","span":{"begin":93,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G93729MV\""},{"id":"GlycanIUPAC_T193","span":{"begin":150,"end":156},"obj":"\"http://rdf.glycoinfo.org/glycan/G93729MV\""},{"id":"GlycanIUPAC_T200","span":{"begin":43,"end":49},"obj":"\"http://rdf.glycoinfo.org/glycan/G92144AE\""},{"id":"GlycanIUPAC_T201","span":{"begin":93,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G92144AE\""},{"id":"GlycanIUPAC_T202","span":{"begin":150,"end":156},"obj":"\"http://rdf.glycoinfo.org/glycan/G92144AE\""}],"text":"Aryl-N-acetyl-alpha-galactosaminides (aryl-GalNAc) are acceptor substrates for UDP-Gal:alpha-GalNAc beta 1-3 galactosyltransferase and, in vivo, aryl-GalNAc have been shown to inhibit O-linked oligosaccharide biosynthesis (Kuan et al., J. Biol. Chem. 264, 19271, 1989)."}

{"project":"Lectin","denotations":[{"id":"Lectin_T1","span":{"begin":231,"end":233},"obj":"https://acgg.asia/db/lfdb/LfDB0344"}],"text":"Aryl-N-acetyl-alpha-galactosaminides (aryl-GalNAc) are acceptor substrates for UDP-Gal:alpha-GalNAc beta 1-3 galactosyltransferase and, in vivo, aryl-GalNAc have been shown to inhibit O-linked oligosaccharide biosynthesis (Kuan et al., J. Biol. Chem. 264, 19271, 1989)."}

{"project":"Glycan-GlyCosmos","denotations":[{"id":"T2","span":{"begin":43,"end":49},"obj":"Glycan"},{"id":"T3","span":{"begin":93,"end":99},"obj":"Glycan"},{"id":"T4","span":{"begin":150,"end":156},"obj":"Glycan"}],"attributes":[{"id":"A2","pred":"glycosmos_id","subj":"T2","obj":"https://glycosmos.org/glycans/show/G39738WL"},{"id":"A11","pred":"image","subj":"T2","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL"},{"id":"A3","pred":"glycosmos_id","subj":"T3","obj":"https://glycosmos.org/glycans/show/G39738WL"},{"id":"A12","pred":"image","subj":"T3","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL"},{"id":"A4","pred":"glycosmos_id","subj":"T4","obj":"https://glycosmos.org/glycans/show/G39738WL"},{"id":"A13","pred":"image","subj":"T4","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL"}],"text":"Aryl-N-acetyl-alpha-galactosaminides (aryl-GalNAc) are acceptor substrates for UDP-Gal:alpha-GalNAc beta 1-3 galactosyltransferase and, in vivo, aryl-GalNAc have been shown to inhibit O-linked oligosaccharide biosynthesis (Kuan et al., J. Biol. Chem. 264, 19271, 1989)."}

{"project":"sentences","denotations":[{"id":"TextSentencer_T2","span":{"begin":0,"end":238},"obj":"Sentence"},{"id":"TextSentencer_T3","span":{"begin":239,"end":244},"obj":"Sentence"},{"id":"TextSentencer_T4","span":{"begin":245,"end":250},"obj":"Sentence"},{"id":"TextSentencer_T5","span":{"begin":251,"end":269},"obj":"Sentence"},{"id":"T2","span":{"begin":0,"end":269},"obj":"Sentence"},{"id":"T2","span":{"begin":0,"end":238},"obj":"Sentence"},{"id":"T3","span":{"begin":239,"end":244},"obj":"Sentence"},{"id":"T4","span":{"begin":245,"end":250},"obj":"Sentence"},{"id":"T5","span":{"begin":251,"end":269},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Aryl-N-acetyl-alpha-galactosaminides (aryl-GalNAc) are acceptor substrates for UDP-Gal:alpha-GalNAc beta 1-3 galactosyltransferase and, in vivo, aryl-GalNAc have been shown to inhibit O-linked oligosaccharide biosynthesis (Kuan et al., J. Biol. Chem. 264, 19271, 1989)."}

{"project":"GlyCosmos15-Sentences","blocks":[{"id":"T2","span":{"begin":0,"end":269},"obj":"Sentence"}],"text":"Aryl-N-acetyl-alpha-galactosaminides (aryl-GalNAc) are acceptor substrates for UDP-Gal:alpha-GalNAc beta 1-3 galactosyltransferase and, in vivo, aryl-GalNAc have been shown to inhibit O-linked oligosaccharide biosynthesis (Kuan et al., J. Biol. Chem. 264, 19271, 1989)."}

{"project":"GlyCosmos15-Glycan","denotations":[{"id":"T2","span":{"begin":43,"end":49},"obj":"Glycan"},{"id":"T3","span":{"begin":93,"end":99},"obj":"Glycan"},{"id":"T4","span":{"begin":150,"end":156},"obj":"Glycan"}],"attributes":[{"id":"A2","pred":"glycosmos_id","subj":"T2","obj":"https://glycosmos.org/glycans/show/G39738WL"},{"id":"A11","pred":"image","subj":"T2","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL"},{"id":"A3","pred":"glycosmos_id","subj":"T3","obj":"https://glycosmos.org/glycans/show/G39738WL"},{"id":"A12","pred":"image","subj":"T3","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL"},{"id":"A4","pred":"glycosmos_id","subj":"T4","obj":"https://glycosmos.org/glycans/show/G39738WL"},{"id":"A13","pred":"image","subj":"T4","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL"}],"text":"Aryl-N-acetyl-alpha-galactosaminides (aryl-GalNAc) are acceptor substrates for UDP-Gal:alpha-GalNAc beta 1-3 galactosyltransferase and, in vivo, aryl-GalNAc have been shown to inhibit O-linked oligosaccharide biosynthesis (Kuan et al., J. Biol. Chem. 264, 19271, 1989)."}